Therapeutic potential of targeting ATM-PELP1-p53 axis in triple negative breast cancer

被引：0
|
作者：
Krishnan, S. R. [1 ]
Nair, B. C. [1 ]
Sareddy, G. R. [1 ]
Mann, M. [1 ]
Roy, S. S. [1 ]
Vadlamudi, R. K. [1 ]
机构：
[1] UTHSCSA, San Antonio, TX USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-PD09-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD09-07
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
    Cortez, Valerie
    Mann, Monica
    Tekmal, Seshidhar
    Suzuki, Takayoshi
    Miyata, Naoki
    Rodriguez-Aguayo, Cristian
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Vadlamudi, Ratna K.
    BREAST CANCER RESEARCH, 2012, 14 (04):
  • [2] Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
    Valerie Cortez
    Monica Mann
    Seshidhar Tekmal
    Takayoshi Suzuki
    Naoki Miyata
    Cristian Rodriguez-Aguayo
    Gabriel Lopez-Berestein
    Anil K Sood
    Ratna K Vadlamudi
    Breast Cancer Research, 14
  • [3] Erratum to: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
    Valerie Cortez
    Monica Mann
    Seshidhar Tekmal
    Takayoshi Suzuki
    Naoki Miyata
    Cristian Rodriguez-Aguayo
    Gabriel Lopez-Berestein
    Anil K Sood
    Ratna K Vadlamudi
    Breast Cancer Research, 14
  • [4] Significance and therapeutic potential of PELP1 axis in ER-negative breast cancer
    Vadlamudi, Ratna K.
    Roy, Sudipa Saha
    CANCER RESEARCH, 2011, 71
  • [5] Targeting triple negative breast cancer: Is p53 the answer?
    Turner, Natalie
    Moretti, Erica
    Siclari, Olimpia
    Migliaccio, Ilenia
    Santarpia, Libero
    D'Incalci, Maurizio
    Piccolo, Stefano
    Veronesi, Andrea
    Zambelli, Alberto
    Del Sal, Gianni
    Di Leo, Angelo
    CANCER TREATMENT REVIEWS, 2013, 39 (05) : 541 - 550
  • [6] Therapeutic potential of ERK5 targeting in triple negative breast cancer
    Jesus Ortiz-Ruiz, Maria
    Alvarez-Fernandez, Stela
    Parrott, Tracy
    Zaknoen, Sara
    Burrows, Francis J.
    Ocana, Alberto
    Pandiella, Atanasio
    Esparis-Ogando, Azucena
    ONCOTARGET, 2014, 5 (22) : 11308 - 11318
  • [7] Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
    Wei-Gang Qiu
    Alla Polotskaia
    Gu Xiao
    Lia Di
    Yuhan Zhao
    Wenwei Hu
    John Philip
    Ronald C. Hendrickson
    Jill Bargonetti
    npj Breast Cancer, 3
  • [8] Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer
    Qiu, Wei-Gang
    Polotskaia, Alla
    Xiao, Gu
    Di, Lia
    Zhao, Yuhan
    Hu, Wenwei
    Philip, John
    Hendrickson, Ronald C.
    Bargonetti, Jill
    NPJ BREAST CANCER, 2017, 3
  • [9] Therapeutic targeting of ERβ in triple negative breast cancer
    Reese, Jordan M.
    Subramaniam, Malayannan
    Suman, Vera J.
    Wu, Xianglin
    Negron, Vivian
    Gingery, Anne
    Pitel, Kevin S.
    Shah, Sejal S.
    Cunliffe, Heather E.
    McCullough, Ann E.
    Pockaj, Barbara A.
    Spelsberg, Thomas C.
    Goetz, Matthew P.
    Ingle, James N.
    Hawse, John R.
    CANCER RESEARCH, 2015, 75
  • [10] Significance and therapeutic potential of PELP1-mTOR axis in breast cancer progression and therapy resistance
    Gonugunta, V. K.
    Cortez, V.
    Sareddy, G. R.
    Roy, S. S.
    Zhang, H.
    Tekmal, R. R.
    Vadlamudi, R. K.
    CANCER RESEARCH, 2012, 72
12345